<DOC>
	<DOCNO>NCT00743236</DOCNO>
	<brief_summary>RATIONALE : Warm ischemia clamp blood vessel without cool kidney . Cold ischemia clamp blood vessel kidney cool . It yet know whether warm ischemia effective cold ischemia patient undergo surgery stage I kidney cancer . PURPOSE : This randomized phase III trial study warm ischemia see well work compare cold ischemia surgery treat patient stage I kidney cancer .</brief_summary>
	<brief_title>Warm Ischemia Cold Ischemia During Surgery Treating Patients With Stage I Kidney Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine effect warm ischemia partial nephrectomy long-term renal function patient solitary stage I renal cortical tumor normal contralateral kidney . Secondary - Determine degree contralateral kidney compensates damage inflict operate kidney surgery . - Determine 1-year disease-specific overall survival patient . OUTLINE : This multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo warm ischemia follow partial nephrectomy . - Arm II : Patients undergo cold ischemia follow partial nephrectomy . Blood urine sample collect periodically nephrectomy assess renal function . Patients follow 1 , 3 , 6 , 9 , 12 month nephrectomy .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis solitary renal cortical tumor Tumor size â‰¤ 4 cm Candidate open partial nephrectomy Expected ischemia time &lt; 45 minute Normal renal function , define glomerular filtration rate ( GFR ) &gt; 60 mL/min No evidence distant metastasis No evidence local invasion adjacent structure , include adrenal gland No evidence tumor extension renal venous system No evidence ureteral obstruction MAG3 renal scan No family history renal cancer PATIENT CHARACTERISTICS : ECOG performance status 0 Life expectancy &gt; 5 year No prior malignancy , except nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>perioperative/postoperative complication</keyword>
	<keyword>urinary complication</keyword>
	<keyword>long-term effect secondary cancer therapy adult</keyword>
	<keyword>stage I renal cell cancer</keyword>
</DOC>